Review




Structured Review

Jackson Laboratory nucleolin heterozygous knockout mice
Ischemic cortical stroke increases <t>nucleolin</t> expression in excitatory neurons (A) Representative coronal section stained with DAPI with stroke (red dashed line) and area of interest (yellow box). (B) Representative in situ hybridization images of DAPI (nuclear counterstain), Slc17a7 (excitatory cortical neurons), Gad1 (inhibitory neurons), and nucleolin at time points across acute to chronic stroke. The dashed box indicates the region shown at higher resolution and magnification in accompanying panels. Scale bars, 20 μm, n = 5 animals per time point. (C) Quantification of nucleolin mRNA expression in excitatory cortical neurons post-stroke. Stroke induces both early and chronic expression of nucleolin in Slc17a7 + cells. 1-way ANOVA with post-hoc Tukey correction. Data are represented as mean ± SEM with data points representing individual animals. ∗ p = 0.039, ∗∗∗ p = 0.003 (3D post stroke), p = 0.004 (7D post stroke). (D) Quantification of nucleolin mRNA expression in inhibitory cortical neurons post-stroke. No significant change in nucleolin expression was detected in Gad1 + cells. Data are represented as mean ± SEM with data points representing individual animals. (E) Representative images of nucleolin protein expression in sham stroke and 7 days post-stroke mice. Scale bars, 10 μm, n = 5 animals per group. (F) Quantification of nucleolin protein expression post-stroke. Stroke significantly increases nucleolin expression 7 days post-stroke ( p = 0.0005 via t test). Data are represented as mean ± SEM with data points representing individual animals.
Nucleolin Heterozygous Knockout Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+knockout+%26+mutation+database/heterozygous+mice/pmc13253107-22-0-9
Average 86 stars, based on 1 article reviews
nucleolin heterozygous knockout mice - by Bioz Stars, 2026-11
86/100 stars

Images

1) Product Images from "A role for nucleolin in functional improvement in stroke"

Article Title: A role for nucleolin in functional improvement in stroke

Journal: iScience

doi: 10.1016/j.isci.2026.116134

Ischemic cortical stroke increases nucleolin expression in excitatory neurons (A) Representative coronal section stained with DAPI with stroke (red dashed line) and area of interest (yellow box). (B) Representative in situ hybridization images of DAPI (nuclear counterstain), Slc17a7 (excitatory cortical neurons), Gad1 (inhibitory neurons), and nucleolin at time points across acute to chronic stroke. The dashed box indicates the region shown at higher resolution and magnification in accompanying panels. Scale bars, 20 μm, n = 5 animals per time point. (C) Quantification of nucleolin mRNA expression in excitatory cortical neurons post-stroke. Stroke induces both early and chronic expression of nucleolin in Slc17a7 + cells. 1-way ANOVA with post-hoc Tukey correction. Data are represented as mean ± SEM with data points representing individual animals. ∗ p = 0.039, ∗∗∗ p = 0.003 (3D post stroke), p = 0.004 (7D post stroke). (D) Quantification of nucleolin mRNA expression in inhibitory cortical neurons post-stroke. No significant change in nucleolin expression was detected in Gad1 + cells. Data are represented as mean ± SEM with data points representing individual animals. (E) Representative images of nucleolin protein expression in sham stroke and 7 days post-stroke mice. Scale bars, 10 μm, n = 5 animals per group. (F) Quantification of nucleolin protein expression post-stroke. Stroke significantly increases nucleolin expression 7 days post-stroke ( p = 0.0005 via t test). Data are represented as mean ± SEM with data points representing individual animals.
Figure Legend Snippet: Ischemic cortical stroke increases nucleolin expression in excitatory neurons (A) Representative coronal section stained with DAPI with stroke (red dashed line) and area of interest (yellow box). (B) Representative in situ hybridization images of DAPI (nuclear counterstain), Slc17a7 (excitatory cortical neurons), Gad1 (inhibitory neurons), and nucleolin at time points across acute to chronic stroke. The dashed box indicates the region shown at higher resolution and magnification in accompanying panels. Scale bars, 20 μm, n = 5 animals per time point. (C) Quantification of nucleolin mRNA expression in excitatory cortical neurons post-stroke. Stroke induces both early and chronic expression of nucleolin in Slc17a7 + cells. 1-way ANOVA with post-hoc Tukey correction. Data are represented as mean ± SEM with data points representing individual animals. ∗ p = 0.039, ∗∗∗ p = 0.003 (3D post stroke), p = 0.004 (7D post stroke). (D) Quantification of nucleolin mRNA expression in inhibitory cortical neurons post-stroke. No significant change in nucleolin expression was detected in Gad1 + cells. Data are represented as mean ± SEM with data points representing individual animals. (E) Representative images of nucleolin protein expression in sham stroke and 7 days post-stroke mice. Scale bars, 10 μm, n = 5 animals per group. (F) Quantification of nucleolin protein expression post-stroke. Stroke significantly increases nucleolin expression 7 days post-stroke ( p = 0.0005 via t test). Data are represented as mean ± SEM with data points representing individual animals.

Techniques Used: Expressing, Staining, In Situ Hybridization

Heterozygous deletion of the nucleolin GAR domain is detrimental to post-stroke axonal sprouting (A) Representative in situ hybridization images show reduced nucleolin expression in GAR +/- mice. The dashed box indicates the region shown at higher resolution and magnification in accompanying panels. Scale bars, 20 μm, n = 5 animals per group. (B) Quantification of nucleolin mRNA in GAR wild type (GAR +/+ ) and heterozygous deletion (GAR +/- ) mice. GAR +/- mice show a significant reduction in nucleolin mRNA puncta in excitatory cortical neurons ( p = 0.004 via t test). Data are represented as mean ± SEM with data points representing individual animals. (C) Schematic shows the general surgery procedure. Generated via BioRender. (D) Quantitative cortical mapping of peri-infarct axonal sprouting in GAR heterozygous deletion mice compared to wild type littermates. Injection site noted via white circle. Stroke site indicated via black symbol. Heterozygous deletion of the nucleolin GAR domain significantly decreases peri-infarct axonal sprouting when compared to wild-type littermate controls ( p = 0.006 via Hotelling’s T2 test). (E) Axonal puncta distribution within concentric rings centered at the injection origin (0,0). Heterozygous deletion of the nucleolin GAR domain significantly reduces axon detection at distances greater than 3 mm from the injection site (∗ p = 0.0329, ∗∗ p = 0.00286, and ∗∗∗∗ p < 0.0001, general linear mixed model with post-hoc Tukey’s correction). Data are represented as mean ± SEM. (F) Representative cortical flat-map images of wild-type and heterozygous GAR deletion mice 1 month following cortical stroke. White circle indicates the tracer injection site, and the red dashed circle indicates the outer bounds of infarct. (G) Heterozygous deletion of the nucleolin GAR domain results in an approximately 2-fold increase in infarct size one month post stroke ( p = 0.0078 via t test). n = 5 animals per group for all measurements. Data are represented as mean ± SEM with data points representing individual animals.
Figure Legend Snippet: Heterozygous deletion of the nucleolin GAR domain is detrimental to post-stroke axonal sprouting (A) Representative in situ hybridization images show reduced nucleolin expression in GAR +/- mice. The dashed box indicates the region shown at higher resolution and magnification in accompanying panels. Scale bars, 20 μm, n = 5 animals per group. (B) Quantification of nucleolin mRNA in GAR wild type (GAR +/+ ) and heterozygous deletion (GAR +/- ) mice. GAR +/- mice show a significant reduction in nucleolin mRNA puncta in excitatory cortical neurons ( p = 0.004 via t test). Data are represented as mean ± SEM with data points representing individual animals. (C) Schematic shows the general surgery procedure. Generated via BioRender. (D) Quantitative cortical mapping of peri-infarct axonal sprouting in GAR heterozygous deletion mice compared to wild type littermates. Injection site noted via white circle. Stroke site indicated via black symbol. Heterozygous deletion of the nucleolin GAR domain significantly decreases peri-infarct axonal sprouting when compared to wild-type littermate controls ( p = 0.006 via Hotelling’s T2 test). (E) Axonal puncta distribution within concentric rings centered at the injection origin (0,0). Heterozygous deletion of the nucleolin GAR domain significantly reduces axon detection at distances greater than 3 mm from the injection site (∗ p = 0.0329, ∗∗ p = 0.00286, and ∗∗∗∗ p < 0.0001, general linear mixed model with post-hoc Tukey’s correction). Data are represented as mean ± SEM. (F) Representative cortical flat-map images of wild-type and heterozygous GAR deletion mice 1 month following cortical stroke. White circle indicates the tracer injection site, and the red dashed circle indicates the outer bounds of infarct. (G) Heterozygous deletion of the nucleolin GAR domain results in an approximately 2-fold increase in infarct size one month post stroke ( p = 0.0078 via t test). n = 5 animals per group for all measurements. Data are represented as mean ± SEM with data points representing individual animals.

Techniques Used: In Situ Hybridization, Expressing, Generated, Injection

GAR-induced somatic sequestration of nucleolin enhances post-stroke axonal sprouting (A) Quantitative cortical mapping of post-stroke axonal sprouting in flattened mouse cortex ipsilateral to the stroke. Exogenous GAR-induced somatic sequestration of nucleolin, injection site noted by the white circle, results in a significant increase in axonal sprouting to the adjacent somatosensory cortex compared to Dendra2 control virus ( p = 0.02727 via Hotelling’s T2 test). Stroke indicated via a black symbol. (B) Axonal puncta distribution within concentric rings centered at the injection site (0,0). Somatic sequestration of nucleolin significantly increases axon detection locally and distant from the injection site (∗∗ p = 0.00234, ∗∗∗ p = 0.000486, and ∗∗∗∗ p < 0.0001, general linear mixed model with post-hoc Tukey’s correction). Data are represented as mean ± SEM. (C) Representative flatmap images of mice injected with control and GARWT viruses. The white circle indicates the virus injection site, and the red dashed circle indicates the border of the infarct. Yellow square indicates zoomed in image, showing colocalization of Flag and NeuN in virally transduced cells. Scale bars, 20 μm, n = 5–7 animals per group. (D) Quantification of infarct size. Somatic sequestration of nucleolin does not impact infarct size ( p = 0.6989 via t test). n = 7 animals per group for all measurements. Data are represented as mean ± SEM with data points representing individual animals.
Figure Legend Snippet: GAR-induced somatic sequestration of nucleolin enhances post-stroke axonal sprouting (A) Quantitative cortical mapping of post-stroke axonal sprouting in flattened mouse cortex ipsilateral to the stroke. Exogenous GAR-induced somatic sequestration of nucleolin, injection site noted by the white circle, results in a significant increase in axonal sprouting to the adjacent somatosensory cortex compared to Dendra2 control virus ( p = 0.02727 via Hotelling’s T2 test). Stroke indicated via a black symbol. (B) Axonal puncta distribution within concentric rings centered at the injection site (0,0). Somatic sequestration of nucleolin significantly increases axon detection locally and distant from the injection site (∗∗ p = 0.00234, ∗∗∗ p = 0.000486, and ∗∗∗∗ p < 0.0001, general linear mixed model with post-hoc Tukey’s correction). Data are represented as mean ± SEM. (C) Representative flatmap images of mice injected with control and GARWT viruses. The white circle indicates the virus injection site, and the red dashed circle indicates the border of the infarct. Yellow square indicates zoomed in image, showing colocalization of Flag and NeuN in virally transduced cells. Scale bars, 20 μm, n = 5–7 animals per group. (D) Quantification of infarct size. Somatic sequestration of nucleolin does not impact infarct size ( p = 0.6989 via t test). n = 7 animals per group for all measurements. Data are represented as mean ± SEM with data points representing individual animals.

Techniques Used: Injection, Control, Virus

Nucleolin perturbation enhances post-stroke functional recovery (A) Diagram of grid-walking and pasta matrix tasks, and experimental timeline for task training and assessment post-stroke. (B) Somatic sequestration of nucleolin accelerates recovery in the pasta matrix fine motor control and grid-walking gross motor control tasks. Mice were evaluated for fine motor dexterity as defined by the percentage of baseline pieces of pasta broken. One-week post-stroke, both GARWT + stroke and Control + stroke mice showed a significant deficit in the number of pieces of pasta broken compared to Control alone (∗Control vs. Stroke + Control p = 0.0082, # Control vs. Stroke + GARWT p = 0.0003 via 2-way ANOVA). Three weeks post-stroke, Control + stroke mice continued to show a deficit, whereas GARWT + stroke mice had recovered to a degree with no significant difference from both control groups (∗ Control vs. Control + stroke p = 0.0021, Control vs. GARWT + stroke p = 0.4568, $ Control + stroke vs. GARWT + stroke p = 0.0280 via 2-way ANOVA). By five weeks post-stroke, both groups showed no significant difference from the control groups. N = 8–10 per group. Mice were evaluated for gross motor control as defined by the fold change of baseline percentage right foot faults. One-week post-stroke, Control + stroke and GARWT + stroke mice showed a significant increase in the relative number of foot faults involving the affected limb (∗Control vs. Control + stroke p = 0.0180, # Control vs. GARWT + stroke p = 0.0202 via 2-way ANOVA). At the endpoint of the experiment, 8 weeks post-stroke, Control + stroke mice showed a continued fold change increase in percent foot faults, whereas GARWT + stroke mice were not significantly different from Control alone (∗Control vs. Control + stroke p = 0.0323, Control vs. GARWT + stroke p = 0.3322). n = 12–15 per group. Data are represented as mean ± SEM. (C) Representative DAPI-stained cortical sections of stroke mice treated with control or GARWT virus. Yellow box outlines the peri-infarct region imaged for tissue-level outcomes, red dashed circle indicates infarct bounds. Scale bars, 20 μm. (D) Somatic sequestration of nucleolin has no effect on infarct size or tissue loss. n = 8 per group. p < 0.0001, control vs. control + stroke and control vs. GARWT + stroke via 2-way ANOVA with Tukey’s post-hoc correction. Data are represented as mean ± SEM with data points representing individual animals. (E) Somatic sequestration of nucleolin does not have an effect on Iba1 intensity following cortical stroke. n = 8 per group. Data are represented as mean ± SEM with data points representing individual animals.
Figure Legend Snippet: Nucleolin perturbation enhances post-stroke functional recovery (A) Diagram of grid-walking and pasta matrix tasks, and experimental timeline for task training and assessment post-stroke. (B) Somatic sequestration of nucleolin accelerates recovery in the pasta matrix fine motor control and grid-walking gross motor control tasks. Mice were evaluated for fine motor dexterity as defined by the percentage of baseline pieces of pasta broken. One-week post-stroke, both GARWT + stroke and Control + stroke mice showed a significant deficit in the number of pieces of pasta broken compared to Control alone (∗Control vs. Stroke + Control p = 0.0082, # Control vs. Stroke + GARWT p = 0.0003 via 2-way ANOVA). Three weeks post-stroke, Control + stroke mice continued to show a deficit, whereas GARWT + stroke mice had recovered to a degree with no significant difference from both control groups (∗ Control vs. Control + stroke p = 0.0021, Control vs. GARWT + stroke p = 0.4568, $ Control + stroke vs. GARWT + stroke p = 0.0280 via 2-way ANOVA). By five weeks post-stroke, both groups showed no significant difference from the control groups. N = 8–10 per group. Mice were evaluated for gross motor control as defined by the fold change of baseline percentage right foot faults. One-week post-stroke, Control + stroke and GARWT + stroke mice showed a significant increase in the relative number of foot faults involving the affected limb (∗Control vs. Control + stroke p = 0.0180, # Control vs. GARWT + stroke p = 0.0202 via 2-way ANOVA). At the endpoint of the experiment, 8 weeks post-stroke, Control + stroke mice showed a continued fold change increase in percent foot faults, whereas GARWT + stroke mice were not significantly different from Control alone (∗Control vs. Control + stroke p = 0.0323, Control vs. GARWT + stroke p = 0.3322). n = 12–15 per group. Data are represented as mean ± SEM. (C) Representative DAPI-stained cortical sections of stroke mice treated with control or GARWT virus. Yellow box outlines the peri-infarct region imaged for tissue-level outcomes, red dashed circle indicates infarct bounds. Scale bars, 20 μm. (D) Somatic sequestration of nucleolin has no effect on infarct size or tissue loss. n = 8 per group. p < 0.0001, control vs. control + stroke and control vs. GARWT + stroke via 2-way ANOVA with Tukey’s post-hoc correction. Data are represented as mean ± SEM with data points representing individual animals. (E) Somatic sequestration of nucleolin does not have an effect on Iba1 intensity following cortical stroke. n = 8 per group. Data are represented as mean ± SEM with data points representing individual animals.

Techniques Used: Functional Assay, Control, Staining, Virus

Related Articles

Mouse Assay:

Article Title:
Article Snippet: .. Auto-D2-KO mice were bred at the VAPORHCS Veterinary Medical Unit by crossing Drd2 loxP/loxP mice ( 53 ), obtained from Jonathan Javitch (Columbia University, USA), with heterozygous B6.SJL- Slc6a3 tm1.1(cre)Bkmn /J mice ( 54 ) obtained from the Jackson Laboratory (JAX stock #006660). ..

Article Title: A role for nucleolin in functional improvement in stroke
Article Snippet: .. Nucleolin heterozygous knockout mice , Doron-Mandel et al. , Jackson Laboratories , JAX 037120. .. C57Bl/6J , Jackson Laboratories , 000664.

Knock-Out:

Article Title: A role for nucleolin in functional improvement in stroke
Article Snippet: .. Nucleolin heterozygous knockout mice , Doron-Mandel et al. , Jackson Laboratories , JAX 037120. .. C57Bl/6J , Jackson Laboratories , 000664.

Article Title: A role for nucleolin in functional improvement in stroke
Article Snippet: .. Nucleolin heterozygous knockout mice are available from Jackson Laboratories (JAX 037120). ..

Transgenic Assay:

Article Title: Disruption of the brain-spleen axis impairs monocyte-microglia communication and accelerates disease progression in a mouse model of amyloidosis.
Article Snippet: .. For all experiments, heterozygous 5xFAD transgenic mice (line Tg6799, The Jackson Laboratory) on a C57/BL6-SJL background and wild-type (WT) littermates were used. .. For all experiments, heterozygous 5xFAD transgenic mice (line Tg6799, The Jackson Laboratory) on a C57/BL6-SJL background and wild-type (WT) littermates were used.

other:

Article Title: Age-Dependent Remodeling of the Sciatic Nerve Proteome in 5xFAD Mice Can Be Attenuated by Exercise or Donepezil Treatment to Maintain Neuromuscular Function.
Article Snippet: Heterozygous 5xFAD mice were obtained commercially (Jackson Laboratories, strain #034840).

Article Title: Developmental CA2 perineuronal net reduction restores social memory in Shank3 mutant mice.
Article Snippet: Male and female Shank3B heterozygous mice were purchased from Jackson Laboratories (strain #017688) and paired together for breeding, yielding wildtype (WT), KO, and heterozygous (HET) offspring.

RNA Sequencing:

Article Title: NPAS3-regulated astrocyte mitochondrial bioenergetics is required for cognition.
Article Snippet: .. Heterozygous Npas3+/− (HET) KO mice (16) [a gift from A. Pieper (University of Iowa); strain #031112, the Jackson Laboratory] were used for RNA- seq (E16 to E17) and primary cultures of astrocytes [postnatal day 1 (P1)]. ..



Similar Products

94
Cyagen Biosciences 1600014c10rik knockout mice
1600014c10rik Knockout Mice, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+knockout+%26+mutation+database/1600014C10Rik/pmc13751628-339-0-6
Average 94 stars, based on 1 article reviews
1600014c10rik knockout mice - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Cyagen Biosciences muc1 conditional knockout mice
Distribution of genotypes in the <t> MUC1 </t> gene and associations with the risk of COPD in Southern China
Muc1 Conditional Knockout Mice, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+knockout+%26+mutation+database/Muc1/pmc13745594-582-2-13
Average 93 stars, based on 1 article reviews
muc1 conditional knockout mice - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Inotiv rag2 il2rg double knockout mice r2g2 envigo r2g2 oligonucleotides primers
Distribution of genotypes in the <t> MUC1 </t> gene and associations with the risk of COPD in Southern China
Rag2 Il2rg Double Knockout Mice R2g2 Envigo R2g2 Oligonucleotides Primers, supplied by Inotiv, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+knockout+%26+mutation+database/Rag2-Il2rg+double+knockout+mice/pm42994433-300-210-215
Average 93 stars, based on 1 article reviews
rag2 il2rg double knockout mice r2g2 envigo r2g2 oligonucleotides primers - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Cyagen Biosciences igfbp2 knockout mice
Distribution of genotypes in the <t> MUC1 </t> gene and associations with the risk of COPD in Southern China
Igfbp2 Knockout Mice, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+knockout+%26+mutation+database/Igfbp2/pm42986497-216-9-20
Average 94 stars, based on 1 article reviews
igfbp2 knockout mice - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Cyagen Biosciences smarcd1 knockout mice
Distribution of genotypes in the <t> MUC1 </t> gene and associations with the risk of COPD in Southern China
Smarcd1 Knockout Mice, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+knockout+%26+mutation+database/Smarcd1/pm42988793-409-2-25
Average 94 stars, based on 1 article reviews
smarcd1 knockout mice - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Cyagen Biosciences smarcd1 knockout ko mice
Distribution of genotypes in the <t> MUC1 </t> gene and associations with the risk of COPD in Southern China
Smarcd1 Knockout Ko Mice, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+knockout+%26+mutation+database/Smarcd1/pm42988793-402-0-8
Average 94 stars, based on 1 article reviews
smarcd1 knockout ko mice - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Cyagen Biosciences uterine cx3cl1 conditional knockout mice
Distribution of genotypes in the <t> MUC1 </t> gene and associations with the risk of COPD in Southern China
Uterine Cx3cl1 Conditional Knockout Mice, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+knockout+%26+mutation+database/Cx3cl1/10__1172_slash_jci202874-289-0-41
Average 94 stars, based on 1 article reviews
uterine cx3cl1 conditional knockout mice - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Cyagen Biosciences endothelial cell ec specific tfeb knockout mice tfebecko
Distribution of genotypes in the <t> MUC1 </t> gene and associations with the risk of COPD in Southern China
Endothelial Cell Ec Specific Tfeb Knockout Mice Tfebecko, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+knockout+%26+mutation+database/Tfeb/pm42957749-47-0-14
Average 93 stars, based on 1 article reviews
endothelial cell ec specific tfeb knockout mice tfebecko - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Cyagen Biosciences male nr1h4 knockout mice
Distribution of genotypes in the <t> MUC1 </t> gene and associations with the risk of COPD in Southern China
Male Nr1h4 Knockout Mice, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+knockout+%26+mutation+database/Nr1h4/pm42955947-232-0-12
Average 94 stars, based on 1 article reviews
male nr1h4 knockout mice - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Cyagen Biosciences ttc22 knockout ttc22 ko c57bl 6n mice
(A) Locations of the deleted fragment (1610 bp), amplicons, gRNAs, and primers matched to the <t>Ttc22</t> gene. The conservation status of Ttc22 in placental mammals, including rats, rabbits, and humans, is displayed below. (B) Characterization of Ttc22 genotypes, as determined by PCR and sequencing. The wild-type Ttc22 fragment is too long (2438 bp) to be amplified via regular PCR via the OuterF and OuterR primer sets. (C) IGV view of Ttc22 transcripts in RNA samples from the colons of three male mice with different Ttc22 genotypes, namely, Ttc22 wild-type ( Ttc22 +/+ ), heterozygously deleted ( Ttc22 +/- ), and homozygously deleted ( Ttc22 -/- ) strains, as determined by RNA sequencing. The exon 2&3 region, which is shared by both Ttc22 variants 1 and 2 and is knocked out by CRISPR-Cas9, is highlighted by a red rectangle.
Ttc22 Knockout Ttc22 Ko C57bl 6n Mice, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+knockout+%26+mutation+database/Ttc22/pmc13693868-27-2-12
Average 93 stars, based on 1 article reviews
ttc22 knockout ttc22 ko c57bl 6n mice - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


Distribution of genotypes in the  MUC1  gene and associations with the risk of COPD in Southern China

Journal: Signal Transduction and Targeted Therapy

Article Title: MUC1 attenuates chronic obstructive pulmonary disease through integrated regulation of pulmonary epithelial cell senescence, transdifferentiation, and inflammatory cascades

doi: 10.1038/s41392-026-03056-x

Figure Lengend Snippet: Distribution of genotypes in the MUC1 gene and associations with the risk of COPD in Southern China

Article Snippet: 2AT2 cell-specific Muc1 conditional knockout mice (Sftpc-CreERT2/ Muc1 flox/flox ) were purchased from Cyagen (Suzhou) Biotechnology Co. Ltd. (Suzhou, China).

Techniques:

Stratification analysis on rs4072037 T > C and rs12411216 C > A in  MUC1  in Southern China

Journal: Signal Transduction and Targeted Therapy

Article Title: MUC1 attenuates chronic obstructive pulmonary disease through integrated regulation of pulmonary epithelial cell senescence, transdifferentiation, and inflammatory cascades

doi: 10.1038/s41392-026-03056-x

Figure Lengend Snippet: Stratification analysis on rs4072037 T > C and rs12411216 C > A in MUC1 in Southern China

Article Snippet: 2AT2 cell-specific Muc1 conditional knockout mice (Sftpc-CreERT2/ Muc1 flox/flox ) were purchased from Cyagen (Suzhou) Biotechnology Co. Ltd. (Suzhou, China).

Techniques: Analysis

Effects of SNP rs4072037 T > C on MUC1 protein expression and SNP rs12411216 C > A variants on MUC1 promoter activity. a Western blot image and intensity analysis of MUC1 protein expression in PBMCs from COPD patients carrying the rs4072037 TT or rs4072037 CC genotype. β-actin was taken as the internal control. b Western blot image and intensity analysis of MUC1 protein expression in CSE-treated hAT2 cells transfected with MUC1 overexpression plasmids carrying rs4072037 TT or rs4072037 CC variant. β-actin was taken as the internal control. c The human bronchial epithelial cell line 16HBE cells were transiently transfected with a luciferase reporter plasmid containing the MUC1 promoter sequence carrying the rs12411216 AA or CC variant. MUC1 promoter activity was measured with/without TNF-α (50 ng/mL) or CSE treatment for 24 h. d hAT2 cells were transiently transfected with a luciferase reporter plasmid containing the fragment of MUC1 promoter carrying rs12411216 AA or CC, and MUC1 promoter activity was measured with or without CSE treatment for 48 h. * P < 0.05; ** P < 0.01; *** P < 0.001

Journal: Signal Transduction and Targeted Therapy

Article Title: MUC1 attenuates chronic obstructive pulmonary disease through integrated regulation of pulmonary epithelial cell senescence, transdifferentiation, and inflammatory cascades

doi: 10.1038/s41392-026-03056-x

Figure Lengend Snippet: Effects of SNP rs4072037 T > C on MUC1 protein expression and SNP rs12411216 C > A variants on MUC1 promoter activity. a Western blot image and intensity analysis of MUC1 protein expression in PBMCs from COPD patients carrying the rs4072037 TT or rs4072037 CC genotype. β-actin was taken as the internal control. b Western blot image and intensity analysis of MUC1 protein expression in CSE-treated hAT2 cells transfected with MUC1 overexpression plasmids carrying rs4072037 TT or rs4072037 CC variant. β-actin was taken as the internal control. c The human bronchial epithelial cell line 16HBE cells were transiently transfected with a luciferase reporter plasmid containing the MUC1 promoter sequence carrying the rs12411216 AA or CC variant. MUC1 promoter activity was measured with/without TNF-α (50 ng/mL) or CSE treatment for 24 h. d hAT2 cells were transiently transfected with a luciferase reporter plasmid containing the fragment of MUC1 promoter carrying rs12411216 AA or CC, and MUC1 promoter activity was measured with or without CSE treatment for 48 h. * P < 0.05; ** P < 0.01; *** P < 0.001

Article Snippet: 2AT2 cell-specific Muc1 conditional knockout mice (Sftpc-CreERT2/ Muc1 flox/flox ) were purchased from Cyagen (Suzhou) Biotechnology Co. Ltd. (Suzhou, China).

Techniques: Expressing, Activity Assay, Western Blot, Analysis, Control, Transfection, Over Expression, Variant Assay, Luciferase, Plasmid Preparation, Sequencing

MUC1-C expression patterns in lung tissues from patients with COPD, cigarette smoke-exposed mouse models, and naturally aged mice. a Immunofluorescence images of MUC1-C (green) expression in lung tissues from healthy adults (≤50 years), adult COPD patients (≤50 years), old healthy individuals (≥70 years), and old COPD patients (≥70 years). SFTPC (red) was used to mark AT2 cells, with DAPI staining (blue) for nuclear visualization (scale bar, 200 μm). b Immunofluorescence images of Muc1-C (green) expression and distribution in the airway and alveolar epithelium of lung tissues from adult air-exposed mice, adult CS-exposed mice, aged air-exposed mice, and aged CS-exposed mice. SFTPC (red) was used to mark AT2 cells, with DAPI staining (blue) for nuclear visualization (scale bar, 100 μm). c Statistical analysis of the mean intensity of Muc1-C expression in SFTPC + AT2 cells in ( a ) immunofluorescence images. d Immunofluorescence images showing the localization of Muc1-C (green) in the nucleus (DAPI, blue) and mitochondria (TOM20, red) in lung tissues from air-exposed and CS-exposed adult mice. STFPC (red) was used to mark AT2 cells (scale bar, 10 μm upper panels and 5 μm lower panels). e Statistical analysis of the integrated MUC1-C intensity of immunofluorescence images in nuclear (DAPI) and mitochondria (TOM20) in ( d ). f Western blot image and intensity analysis of Muc1-C protein expression in lung tissues from naturally aged wild-type mice with 3-month-old (3mo), 6-month-old (6mo), and 18-month-old (18mo) GAPDH was taken as the internal control ( n = 8 per group). g Western blot images and intensity analysis of MUC1-C protein expression in lung tissues from adult and aged mice with/without CS exposure ( n = 6 per group). β-actin was taken as the internal control

Journal: Signal Transduction and Targeted Therapy

Article Title: MUC1 attenuates chronic obstructive pulmonary disease through integrated regulation of pulmonary epithelial cell senescence, transdifferentiation, and inflammatory cascades

doi: 10.1038/s41392-026-03056-x

Figure Lengend Snippet: MUC1-C expression patterns in lung tissues from patients with COPD, cigarette smoke-exposed mouse models, and naturally aged mice. a Immunofluorescence images of MUC1-C (green) expression in lung tissues from healthy adults (≤50 years), adult COPD patients (≤50 years), old healthy individuals (≥70 years), and old COPD patients (≥70 years). SFTPC (red) was used to mark AT2 cells, with DAPI staining (blue) for nuclear visualization (scale bar, 200 μm). b Immunofluorescence images of Muc1-C (green) expression and distribution in the airway and alveolar epithelium of lung tissues from adult air-exposed mice, adult CS-exposed mice, aged air-exposed mice, and aged CS-exposed mice. SFTPC (red) was used to mark AT2 cells, with DAPI staining (blue) for nuclear visualization (scale bar, 100 μm). c Statistical analysis of the mean intensity of Muc1-C expression in SFTPC + AT2 cells in ( a ) immunofluorescence images. d Immunofluorescence images showing the localization of Muc1-C (green) in the nucleus (DAPI, blue) and mitochondria (TOM20, red) in lung tissues from air-exposed and CS-exposed adult mice. STFPC (red) was used to mark AT2 cells (scale bar, 10 μm upper panels and 5 μm lower panels). e Statistical analysis of the integrated MUC1-C intensity of immunofluorescence images in nuclear (DAPI) and mitochondria (TOM20) in ( d ). f Western blot image and intensity analysis of Muc1-C protein expression in lung tissues from naturally aged wild-type mice with 3-month-old (3mo), 6-month-old (6mo), and 18-month-old (18mo) GAPDH was taken as the internal control ( n = 8 per group). g Western blot images and intensity analysis of MUC1-C protein expression in lung tissues from adult and aged mice with/without CS exposure ( n = 6 per group). β-actin was taken as the internal control

Article Snippet: 2AT2 cell-specific Muc1 conditional knockout mice (Sftpc-CreERT2/ Muc1 flox/flox ) were purchased from Cyagen (Suzhou) Biotechnology Co. Ltd. (Suzhou, China).

Techniques: Expressing, Immunofluorescence, DAPI Staining, Analysis, Western Blot, Control

Muc1 deficiency predisposes to exacerbated COPD development through enhanced inflammation, suppressed transdifferentiation of AT2-to-AT1, and accelerated senescence of pulmonary epithelium cells. a Pulmonary function parameters measured in Muc1 +/+ and Muc1 −/− mice exposed to air or CS, including functional residual capacity (FRC), forced vital capacity (FVC), and forced expiratory volume at 100 milliseconds/FVC ratio (FEV100 /FVC) ( n = 11–13 per group). b H&E staining and quantification of the mean linear intercept (MLI) in lung tissues from Muc1 +/+ and Muc1 −/− mice exposed to air or CS ( n = 6 per group; scale bar, 50 μm). c Pulmonary function parameters measured in Muc1 AT2 +/+ and Muc1 AT2 −/− mice exposed to air or CS, including FRC, FEV20/FVC, and FEV50/FVC ( n = 5–6 per group). d H&E staining and quantification of the MLI in lung tissues from Muc1 AT2 +/+ and Muc1 AT2 −/− mice exposed to air or CS ( n = 5 per group; scale bar, 200 μm). e Inflammatory cell counts in BALF from Muc1 +/+ and Muc1 −/− mice exposed to air or CS, including: total leukocyte, neutrophil, macrophage, and lymphocyte counts ( n = 11 per group). f ELISA measurement of IL-1β and IL-6 levels in BALF from Muc1 +/+ and Muc1 −/− mice exposed to air or CS ( n = 11 per group). g Western blot image and intensity analysis of PDPN, and AQP5 protein expression in lung tissues from Muc1 AT2 +/+ and Muc1 AT2 −/− mice exposed to air or CS. β-actin was taken as the internal control ( n = 3 per group). h , i Pulmonary function parameters measured in Muc1 +/+ and Muc1 −/− mice aged 3–18 months, including inspiratory capacity (IC) and FEV100/FVC ratio, with statistical analysis of IC and FEV100/FVC ratio in 18-month-old mice, respectively ( n = 5–8 per group, * P < 0.05, *** P < 0.001). j H&E staining of lung tissues from Muc1 −/− and Muc1 +/+ mice aged 3, 6, 18 months, with quantification of the MLI in lung tissues from these groups ( n > 5 per group; scale bar, 200 μm). k Immunofluorescence images of p53 (green) expression and distribution in the lung tissues from Muc1 +/+ and Muc1 −/− mice aged 3 and 18 months. SFTPC (red) was used to mark AT2 cells, with DAPI staining (blue) for nuclear visualization (scale bar, 200 μm)

Journal: Signal Transduction and Targeted Therapy

Article Title: MUC1 attenuates chronic obstructive pulmonary disease through integrated regulation of pulmonary epithelial cell senescence, transdifferentiation, and inflammatory cascades

doi: 10.1038/s41392-026-03056-x

Figure Lengend Snippet: Muc1 deficiency predisposes to exacerbated COPD development through enhanced inflammation, suppressed transdifferentiation of AT2-to-AT1, and accelerated senescence of pulmonary epithelium cells. a Pulmonary function parameters measured in Muc1 +/+ and Muc1 −/− mice exposed to air or CS, including functional residual capacity (FRC), forced vital capacity (FVC), and forced expiratory volume at 100 milliseconds/FVC ratio (FEV100 /FVC) ( n = 11–13 per group). b H&E staining and quantification of the mean linear intercept (MLI) in lung tissues from Muc1 +/+ and Muc1 −/− mice exposed to air or CS ( n = 6 per group; scale bar, 50 μm). c Pulmonary function parameters measured in Muc1 AT2 +/+ and Muc1 AT2 −/− mice exposed to air or CS, including FRC, FEV20/FVC, and FEV50/FVC ( n = 5–6 per group). d H&E staining and quantification of the MLI in lung tissues from Muc1 AT2 +/+ and Muc1 AT2 −/− mice exposed to air or CS ( n = 5 per group; scale bar, 200 μm). e Inflammatory cell counts in BALF from Muc1 +/+ and Muc1 −/− mice exposed to air or CS, including: total leukocyte, neutrophil, macrophage, and lymphocyte counts ( n = 11 per group). f ELISA measurement of IL-1β and IL-6 levels in BALF from Muc1 +/+ and Muc1 −/− mice exposed to air or CS ( n = 11 per group). g Western blot image and intensity analysis of PDPN, and AQP5 protein expression in lung tissues from Muc1 AT2 +/+ and Muc1 AT2 −/− mice exposed to air or CS. β-actin was taken as the internal control ( n = 3 per group). h , i Pulmonary function parameters measured in Muc1 +/+ and Muc1 −/− mice aged 3–18 months, including inspiratory capacity (IC) and FEV100/FVC ratio, with statistical analysis of IC and FEV100/FVC ratio in 18-month-old mice, respectively ( n = 5–8 per group, * P < 0.05, *** P < 0.001). j H&E staining of lung tissues from Muc1 −/− and Muc1 +/+ mice aged 3, 6, 18 months, with quantification of the MLI in lung tissues from these groups ( n > 5 per group; scale bar, 200 μm). k Immunofluorescence images of p53 (green) expression and distribution in the lung tissues from Muc1 +/+ and Muc1 −/− mice aged 3 and 18 months. SFTPC (red) was used to mark AT2 cells, with DAPI staining (blue) for nuclear visualization (scale bar, 200 μm)

Article Snippet: 2AT2 cell-specific Muc1 conditional knockout mice (Sftpc-CreERT2/ Muc1 flox/flox ) were purchased from Cyagen (Suzhou) Biotechnology Co. Ltd. (Suzhou, China).

Techniques: Functional Assay, Staining, Enzyme-linked Immunosorbent Assay, Western Blot, Analysis, Expressing, Control, Immunofluorescence, DAPI Staining

AAV9-mediated cell-specific reconstitution of Muc1 in pulmonary epithelial cells ameliorates COPD through coordinated suppression of pulmonary inflammation, mitochondrial function, and hAT2 transdifferentiation. a Schematic illustration of the experimental design for adult mice exposed to air or CS and treated with AAV9-Sftpc-Muc1-EGFP (AAV9-Muc1) or AAV9-Sftpc-NC-EGFP (AAV9-NC) vectors. Mice were exposed to air or CS for 3 months, followed by intra-airway instillation of AAV9-mediated vectors, and continued on the same exposure regimen for another 3 months before evaluation. b Representative in vivo fluorescence and X-ray images of adult mice exposed to air or CS and treated with AAV9-NC or AAV9-Muc1. c Body weight changes were monitored in aged (12-month-old) and adult (2-month-old) mice treated with AAV9-Muc1 or AAV9-NC during the 6-month air or CS exposure. d Pulmonary function parameters measured at the end of the modeling period in both aged and adult mice treated with AAV9-Muc1 or AAV9-NC, including FRC, FVC, IC, and FEV50/FVC. e Western blot image and intensity analysis of Muc1-C protein expression in lung tissues from aged mice, including air-exposed controls, and CS-exposed mice treated with either AAV9-NC or AAV9-Muc1. β-actin was taken as the internal control ( n = 4 per group). f Immunofluorescence images of the expression of Muc1-C (green) in lung tissues from aged mice exposed to CS, treated with AAV9-NC or AAV9-Muc1. SFTPC was used to mark AT2 cells, with DAPI staining (blue) for nuclear visualization (scale bar, 100 μm). g H&E staining of lung tissues from aged and adult mice, treated with AAV9-Muc1 or treated with AAV9-NC, with or without CS exposure, with quantification of the MLI in lung tissue from these groups ( n = 8 per group; scale bar, 200 μm). h H&E staining of BALF cells from aged and adult mice, treated with AAV9-Muc1 or AAV9-NC, with or without CS exposure (scale bar, 200 μm), with quantification of total cell count in BALF. i Representative chest Micro-CT images of adult and aged mice exposed to air or CS, treated with AAV9-NC or AAV9-Muc1. Aged mice exposed to air without AAV9 treatment were included as additional controls. j Transmission electron microscopy (TEM) images showing mitochondrial morphology in lung tissues from adult mice treated with AAV9-NC or AAV9-Muc1 under air or CS exposure, and aged mice under air exposure or treated with AAV9-NC or AAV9-Muc1 under CS exposure (scale bar, 5 μm upper panels and 1 μm lower panels). k , l Western blot image and intensity analysis of SFTPC and AQP5 proteins expression in lung tissues from adult mice exposed to air or CS and treated with either AAV9-NC or AAV9-Muc1 ( n = 4 per group). β-actin was taken as the internal control. m Immunofluorescence images of SFTPC (green) and AQP5 (red) in lung tissues from adult mice exposed to air or CS and treated with either AAV9-NC or AAV9-Muc1. DAPI staining (blue) was used for nuclear visualization (scale bar, 100 μm)

Journal: Signal Transduction and Targeted Therapy

Article Title: MUC1 attenuates chronic obstructive pulmonary disease through integrated regulation of pulmonary epithelial cell senescence, transdifferentiation, and inflammatory cascades

doi: 10.1038/s41392-026-03056-x

Figure Lengend Snippet: AAV9-mediated cell-specific reconstitution of Muc1 in pulmonary epithelial cells ameliorates COPD through coordinated suppression of pulmonary inflammation, mitochondrial function, and hAT2 transdifferentiation. a Schematic illustration of the experimental design for adult mice exposed to air or CS and treated with AAV9-Sftpc-Muc1-EGFP (AAV9-Muc1) or AAV9-Sftpc-NC-EGFP (AAV9-NC) vectors. Mice were exposed to air or CS for 3 months, followed by intra-airway instillation of AAV9-mediated vectors, and continued on the same exposure regimen for another 3 months before evaluation. b Representative in vivo fluorescence and X-ray images of adult mice exposed to air or CS and treated with AAV9-NC or AAV9-Muc1. c Body weight changes were monitored in aged (12-month-old) and adult (2-month-old) mice treated with AAV9-Muc1 or AAV9-NC during the 6-month air or CS exposure. d Pulmonary function parameters measured at the end of the modeling period in both aged and adult mice treated with AAV9-Muc1 or AAV9-NC, including FRC, FVC, IC, and FEV50/FVC. e Western blot image and intensity analysis of Muc1-C protein expression in lung tissues from aged mice, including air-exposed controls, and CS-exposed mice treated with either AAV9-NC or AAV9-Muc1. β-actin was taken as the internal control ( n = 4 per group). f Immunofluorescence images of the expression of Muc1-C (green) in lung tissues from aged mice exposed to CS, treated with AAV9-NC or AAV9-Muc1. SFTPC was used to mark AT2 cells, with DAPI staining (blue) for nuclear visualization (scale bar, 100 μm). g H&E staining of lung tissues from aged and adult mice, treated with AAV9-Muc1 or treated with AAV9-NC, with or without CS exposure, with quantification of the MLI in lung tissue from these groups ( n = 8 per group; scale bar, 200 μm). h H&E staining of BALF cells from aged and adult mice, treated with AAV9-Muc1 or AAV9-NC, with or without CS exposure (scale bar, 200 μm), with quantification of total cell count in BALF. i Representative chest Micro-CT images of adult and aged mice exposed to air or CS, treated with AAV9-NC or AAV9-Muc1. Aged mice exposed to air without AAV9 treatment were included as additional controls. j Transmission electron microscopy (TEM) images showing mitochondrial morphology in lung tissues from adult mice treated with AAV9-NC or AAV9-Muc1 under air or CS exposure, and aged mice under air exposure or treated with AAV9-NC or AAV9-Muc1 under CS exposure (scale bar, 5 μm upper panels and 1 μm lower panels). k , l Western blot image and intensity analysis of SFTPC and AQP5 proteins expression in lung tissues from adult mice exposed to air or CS and treated with either AAV9-NC or AAV9-Muc1 ( n = 4 per group). β-actin was taken as the internal control. m Immunofluorescence images of SFTPC (green) and AQP5 (red) in lung tissues from adult mice exposed to air or CS and treated with either AAV9-NC or AAV9-Muc1. DAPI staining (blue) was used for nuclear visualization (scale bar, 100 μm)

Article Snippet: 2AT2 cell-specific Muc1 conditional knockout mice (Sftpc-CreERT2/ Muc1 flox/flox ) were purchased from Cyagen (Suzhou) Biotechnology Co. Ltd. (Suzhou, China).

Techniques: In Vivo, Fluorescence, Western Blot, Analysis, Expressing, Control, Immunofluorescence, DAPI Staining, Staining, Tissue, Cell Characterization, Micro-CT, Transmission Assay, Electron Microscopy, Morphology

MUC1 attenuates senescence-associated alveolar epithelial dysfunction through coordinated activation of PINK1/Parkin-dependent mitophagy flux and AMPK/NDUFS4-driven mitochondrial metabolic reprogramming. a Immunofluorescence images showing LC3B (green), TOM20 (red), and SFTPC (purple) in lung tissues from four groups of mice including wild-type mice exposed to air ( Muc1 AT2+/+ , Air), wild-type mice exposed to CS ( Muc1 AT2+/+ , CS), AT2-specific Muc1 knockout mice exposed to air ( Muc1 AT2−/− , Air), and AT2-specific Muc1 knockout mice exposed to CS ( Muc1 AT2−/− , CS). DAPI (blue) was used for nuclear staining ( n = 4 per group; scale bar, 100 μm). Values are LC3B-TOM20 colocalization coefficients in lung tissues calculated using the Colocalization Finder plugin in ImageJ. b Co-IP using an anti-MUC1-C antibody in highly purified mitochondrial fractions isolated from A549 cells after 48 h of CSE stimulation, followed by western blot detection of ATAD3A and MUC1-C. c Western blot image and intensity analysis of Pink1, Parkin, MUC1-C, and TOM20 proteins expression in A549 cells transfected with sh MUC1 or shNC with or without CSE stimulation for 48 h ( n = 3 per group). β-actin was taken as the internal control. d Western blot image and intensity analysis of MUC1-C, LC3B-I, and LC3B-II proteins expression in hAT2 cells transfected with MUC1-C overexpression plasmids (oeMUC1-C) or control vectors (oeNC), with or without CSE stimulation for 48 h ( n = 4 per group). β-actin was taken as the internal control. e Western blot image and intensity analysis of MUC1-C and NDUFS4 proteins expression in A549 cells transfected with CRISPR/Cas9-mediated MUC1 knockout (sg MUC1 ) or scrambled negative control (sgNC) plasmids, with or without CSE stimulation for 48 h ( n = 6 per group). β-actin was taken as the internal control. f Western blot analysis and intensity analysis of NDUFS4, TOM22, and MUC1-C proteins expression in hAT2 cells subjected to CRISPR/ Cas9-mediated MUC1 knockout (sg MUC1 vs. sgNC) or transfected with either wild-type MUC1-CQC (oeMUC1-CQC) or the point mutant MUC1-AQA (oeMUC1-AQA), with or without CSE stimulation for 48 h ( n = 4 per group). β-actin was taken as the internal control. g Co-IP using an anti-MUC1-C antibody in mitochondrial fractions isolated from A549 cells treated with CSE for 48 h, followed by western blot detection of MUC1-C, phosphorylated AMPK (p-AMPK), NDUFS4, and TOM22. h Western blot image of phosphorylated AMPK (p-AMPK), AMPK, and MUC1-C proteins expression in highly purified mitochondrial and cytoplasmic fractions isolated from A549 cells transfected with shNC or sh MUC1-C , with or without CSE stimulation for 48 h. β-Tubulin and COX IV were taken as the internal controls for cytoplasmic and mitochondrial fractions, respectively. i Cellular NAD⁺, NADH, and NAD⁺/NADH ratio were measured in A549 cells transfected with CRISPR/Cas9-mediated MUC1 knockout (sg MUC1 ) or scrambled negative controls (sgNC), with or without CSE stimulation for 48 h ( n = 3 per group). j Western blot image and intensity analysis of HK1, HK2, and MUC1-C proteins expression in hAT2 cells subjected to sg MUC1 or transfected with either oeMUC1-CQC or oeMUC1-AQA, with or without CSE stimulation for 48 h ( n = 4 per group). β-actin was taken as the internal control. k Western blot image and intensity analysis of ATAD3A protein expression in MUC1 -knockout hAT2 cells transfected with ATAD3A overexpression plasmids (oeATAD3A) or control vectors (oeNC). β-actin was taken as the internal control ( n = 4 per group). l Western blot image and intensity analysis of PINK1 protein expression in MUC1 -knockout hAT2 cells transfected with oeATAD3A or oeNC with or without CSE stimulation. β-actin was taken as the internal control ( n = 3 per group). m Western blot image and intensity analysis of AMPK and HK1 protein expression in MUC1 -knockout hAT2 cells transfected with AMPK overexpression plasmids (oeAMPK) or control vectors (oeNC). β-actin was taken as the internal control ( n = 3 per group)

Journal: Signal Transduction and Targeted Therapy

Article Title: MUC1 attenuates chronic obstructive pulmonary disease through integrated regulation of pulmonary epithelial cell senescence, transdifferentiation, and inflammatory cascades

doi: 10.1038/s41392-026-03056-x

Figure Lengend Snippet: MUC1 attenuates senescence-associated alveolar epithelial dysfunction through coordinated activation of PINK1/Parkin-dependent mitophagy flux and AMPK/NDUFS4-driven mitochondrial metabolic reprogramming. a Immunofluorescence images showing LC3B (green), TOM20 (red), and SFTPC (purple) in lung tissues from four groups of mice including wild-type mice exposed to air ( Muc1 AT2+/+ , Air), wild-type mice exposed to CS ( Muc1 AT2+/+ , CS), AT2-specific Muc1 knockout mice exposed to air ( Muc1 AT2−/− , Air), and AT2-specific Muc1 knockout mice exposed to CS ( Muc1 AT2−/− , CS). DAPI (blue) was used for nuclear staining ( n = 4 per group; scale bar, 100 μm). Values are LC3B-TOM20 colocalization coefficients in lung tissues calculated using the Colocalization Finder plugin in ImageJ. b Co-IP using an anti-MUC1-C antibody in highly purified mitochondrial fractions isolated from A549 cells after 48 h of CSE stimulation, followed by western blot detection of ATAD3A and MUC1-C. c Western blot image and intensity analysis of Pink1, Parkin, MUC1-C, and TOM20 proteins expression in A549 cells transfected with sh MUC1 or shNC with or without CSE stimulation for 48 h ( n = 3 per group). β-actin was taken as the internal control. d Western blot image and intensity analysis of MUC1-C, LC3B-I, and LC3B-II proteins expression in hAT2 cells transfected with MUC1-C overexpression plasmids (oeMUC1-C) or control vectors (oeNC), with or without CSE stimulation for 48 h ( n = 4 per group). β-actin was taken as the internal control. e Western blot image and intensity analysis of MUC1-C and NDUFS4 proteins expression in A549 cells transfected with CRISPR/Cas9-mediated MUC1 knockout (sg MUC1 ) or scrambled negative control (sgNC) plasmids, with or without CSE stimulation for 48 h ( n = 6 per group). β-actin was taken as the internal control. f Western blot analysis and intensity analysis of NDUFS4, TOM22, and MUC1-C proteins expression in hAT2 cells subjected to CRISPR/ Cas9-mediated MUC1 knockout (sg MUC1 vs. sgNC) or transfected with either wild-type MUC1-CQC (oeMUC1-CQC) or the point mutant MUC1-AQA (oeMUC1-AQA), with or without CSE stimulation for 48 h ( n = 4 per group). β-actin was taken as the internal control. g Co-IP using an anti-MUC1-C antibody in mitochondrial fractions isolated from A549 cells treated with CSE for 48 h, followed by western blot detection of MUC1-C, phosphorylated AMPK (p-AMPK), NDUFS4, and TOM22. h Western blot image of phosphorylated AMPK (p-AMPK), AMPK, and MUC1-C proteins expression in highly purified mitochondrial and cytoplasmic fractions isolated from A549 cells transfected with shNC or sh MUC1-C , with or without CSE stimulation for 48 h. β-Tubulin and COX IV were taken as the internal controls for cytoplasmic and mitochondrial fractions, respectively. i Cellular NAD⁺, NADH, and NAD⁺/NADH ratio were measured in A549 cells transfected with CRISPR/Cas9-mediated MUC1 knockout (sg MUC1 ) or scrambled negative controls (sgNC), with or without CSE stimulation for 48 h ( n = 3 per group). j Western blot image and intensity analysis of HK1, HK2, and MUC1-C proteins expression in hAT2 cells subjected to sg MUC1 or transfected with either oeMUC1-CQC or oeMUC1-AQA, with or without CSE stimulation for 48 h ( n = 4 per group). β-actin was taken as the internal control. k Western blot image and intensity analysis of ATAD3A protein expression in MUC1 -knockout hAT2 cells transfected with ATAD3A overexpression plasmids (oeATAD3A) or control vectors (oeNC). β-actin was taken as the internal control ( n = 4 per group). l Western blot image and intensity analysis of PINK1 protein expression in MUC1 -knockout hAT2 cells transfected with oeATAD3A or oeNC with or without CSE stimulation. β-actin was taken as the internal control ( n = 3 per group). m Western blot image and intensity analysis of AMPK and HK1 protein expression in MUC1 -knockout hAT2 cells transfected with AMPK overexpression plasmids (oeAMPK) or control vectors (oeNC). β-actin was taken as the internal control ( n = 3 per group)

Article Snippet: 2AT2 cell-specific Muc1 conditional knockout mice (Sftpc-CreERT2/ Muc1 flox/flox ) were purchased from Cyagen (Suzhou) Biotechnology Co. Ltd. (Suzhou, China).

Techniques: Activation Assay, Immunofluorescence, Knock-Out, Staining, Co-Immunoprecipitation Assay, Purification, Isolation, Western Blot, Analysis, Expressing, Transfection, Control, Over Expression, CRISPR, Negative Control, Mutagenesis

MUC1 attenuates CSE-induced hAT2 cell transdifferentiation through canonical Wnt/β-catenin signaling activation, mediated by enhanced β-catenin nuclear translocation. a Immunofluorescence images of SFTPC (green), MUC1 (red), and β-catenin (gray) in the lung tissues from mice exposed to air or CS. DAPI (blue) was used for nuclear staining (scale bar, 100 μm). b Western blot imag e and intensity analysis of β-catenin protein expression in lung tissues from mice exposed to air or CS ( n = 6 per group). β-actin was taken as the internal control. c Immunofluorescence images of SFTPC (green), MUC1 (red), and β-catenin (gray) in the lung tissues from mice exposed to air or CS and treated with either AAV9-NC or AAV9-Muc1. DAPI (blue) was used for nuclear staining (scale bar, 100 μm). d Western blot image and intensity analysis of β-catenin protein expression in lung tissues from wild-type mice exposed to air, or to CS, and treated with either AAV9-NC or AAV9-Muc1 ( n = 4 per group). β-actin was taken as the internal control. e Western blot image and intensity analysis of β-catenin protein expression in lung tissues from Muc1 AT2+/+ and Muc1 AT2−/− mice exposed to air or CS ( n = 4 per group). β-actin was taken as the internal control. f Western blot image and intensity analysis of β-catenin protein expression in hAT2 cells transfected with oeMUC1 or oeNC, and treated with or without CSE for 36 h ( n = 6 per group). β-actin was taken as the internal control. g Western blot image and intensity analysis of β-catenin protein expression in cytoplasmic and nuclear fractions of hAT2 cells transfected with oeMUC1 or oeNC, with or without CSE for 36 h ( n = 4 per group). GAPDH and histone H3 were taken as the internal controls for cytoplasmic and nuclear fractions, respectively. h Western blot image and intensity analysis of β-catenin protein expression in nuclear and cytoplasmic fractions of hAT2 cells transfected with either short hairpin RNA of MUC1 (sh MUC1 ) or short hairpin RNA of normal control (shNC), with or without CSE treatment for 36 h ( n = 4 per group). β-tubulin and Histone H3 were taken as the internal controls for cytoplasmic and nuclear fractions, respectively. i Western blot image and intensity analysis of β-catenin, PDPN, and AQP5 proteins expression in hAT2 cells transfected with oeMUC1 or oeNC. Cells were treated with 2% CSE alone or in combination with 10 nmol XAV-939 (Wnt signaling pathway inhibitors) for 36 h. An equivalent volume of DMSO was used as a vehicle control ( n = 4 per group). β-actin was taken as the internal control. j Western blot image and intensity analysis of PINK1 protein expression in hAT2 cells transfected with oeMUC1 or oeNC. Cells were treated with 2% CSE alone or in combination with 10 nmol XAV-939 for 36 h. An equivalent volume of DMSO was used as a vehicle control ( n = 4 per group). β-actin was taken as the internal control. k Western blot image and intensity analysis of HK1, HK2, AMPK, and LDHA proteins expression in hAT2 cells transfected with oeMUC1 or oeNC. Cells were treated with 2% CSE alone or in combination with 10 nmol XAV-939 for 36 h. An equivalent volume of DMSO was used as a vehicle control ( n = 4 per group). β-actin was taken as the internal control

Journal: Signal Transduction and Targeted Therapy

Article Title: MUC1 attenuates chronic obstructive pulmonary disease through integrated regulation of pulmonary epithelial cell senescence, transdifferentiation, and inflammatory cascades

doi: 10.1038/s41392-026-03056-x

Figure Lengend Snippet: MUC1 attenuates CSE-induced hAT2 cell transdifferentiation through canonical Wnt/β-catenin signaling activation, mediated by enhanced β-catenin nuclear translocation. a Immunofluorescence images of SFTPC (green), MUC1 (red), and β-catenin (gray) in the lung tissues from mice exposed to air or CS. DAPI (blue) was used for nuclear staining (scale bar, 100 μm). b Western blot imag e and intensity analysis of β-catenin protein expression in lung tissues from mice exposed to air or CS ( n = 6 per group). β-actin was taken as the internal control. c Immunofluorescence images of SFTPC (green), MUC1 (red), and β-catenin (gray) in the lung tissues from mice exposed to air or CS and treated with either AAV9-NC or AAV9-Muc1. DAPI (blue) was used for nuclear staining (scale bar, 100 μm). d Western blot image and intensity analysis of β-catenin protein expression in lung tissues from wild-type mice exposed to air, or to CS, and treated with either AAV9-NC or AAV9-Muc1 ( n = 4 per group). β-actin was taken as the internal control. e Western blot image and intensity analysis of β-catenin protein expression in lung tissues from Muc1 AT2+/+ and Muc1 AT2−/− mice exposed to air or CS ( n = 4 per group). β-actin was taken as the internal control. f Western blot image and intensity analysis of β-catenin protein expression in hAT2 cells transfected with oeMUC1 or oeNC, and treated with or without CSE for 36 h ( n = 6 per group). β-actin was taken as the internal control. g Western blot image and intensity analysis of β-catenin protein expression in cytoplasmic and nuclear fractions of hAT2 cells transfected with oeMUC1 or oeNC, with or without CSE for 36 h ( n = 4 per group). GAPDH and histone H3 were taken as the internal controls for cytoplasmic and nuclear fractions, respectively. h Western blot image and intensity analysis of β-catenin protein expression in nuclear and cytoplasmic fractions of hAT2 cells transfected with either short hairpin RNA of MUC1 (sh MUC1 ) or short hairpin RNA of normal control (shNC), with or without CSE treatment for 36 h ( n = 4 per group). β-tubulin and Histone H3 were taken as the internal controls for cytoplasmic and nuclear fractions, respectively. i Western blot image and intensity analysis of β-catenin, PDPN, and AQP5 proteins expression in hAT2 cells transfected with oeMUC1 or oeNC. Cells were treated with 2% CSE alone or in combination with 10 nmol XAV-939 (Wnt signaling pathway inhibitors) for 36 h. An equivalent volume of DMSO was used as a vehicle control ( n = 4 per group). β-actin was taken as the internal control. j Western blot image and intensity analysis of PINK1 protein expression in hAT2 cells transfected with oeMUC1 or oeNC. Cells were treated with 2% CSE alone or in combination with 10 nmol XAV-939 for 36 h. An equivalent volume of DMSO was used as a vehicle control ( n = 4 per group). β-actin was taken as the internal control. k Western blot image and intensity analysis of HK1, HK2, AMPK, and LDHA proteins expression in hAT2 cells transfected with oeMUC1 or oeNC. Cells were treated with 2% CSE alone or in combination with 10 nmol XAV-939 for 36 h. An equivalent volume of DMSO was used as a vehicle control ( n = 4 per group). β-actin was taken as the internal control

Article Snippet: 2AT2 cell-specific Muc1 conditional knockout mice (Sftpc-CreERT2/ Muc1 flox/flox ) were purchased from Cyagen (Suzhou) Biotechnology Co. Ltd. (Suzhou, China).

Techniques: Activation Assay, Translocation Assay, Immunofluorescence, Staining, Western Blot, Analysis, Expressing, Control, Transfection, shRNA

MUC1 inhibits CS-induced pulmonary inflammatory responses by suppressing NF-κB-dependent signaling. a ELISA analysis of IL-6 and IL-8 levels in the culture supernatant of 16HBE cells treated with negative control siRNA (siNC) or MUC1 -targeting siRNA (si MUC1 ) for 48 h, followed by treatment with or without CSE for 24 h ( n = 6 per group). Cytokine concentrations were quantified in pg/mL and normalized to total protein content in each sample. b Western blot image and intensity analysis of NF-κB protein expression in the nuclear fraction of 16HBE cells treated with either negative control siRNA (siNC) or MUC1 -targeting siRNA (si MUC1 ) for 48 h, followed by treatment with or without CSE for 1 h ( n = 6 per group). Histone H3 was taken as the internal control. c Western blot image and intensity analysis of NF-κB protein expression in the nuclear fraction from lung tissues of Muc1 +/+ and Muc1 −/− mice exposed to air or CS ( n = 6 per group). Histone H3 was taken as the internal control. d Left: Cold competition assay was performed with nuclear extracts from Muc1 AT2−/− CS-6m mouse lungs. Middle and Right: EMSAs including negative control, cold competition, mutant cold probe competition, and super-shift assays were performed with nuclear extracts from lung tissues of Muc1 AT2+/+ mice with 6 months air exposure (Air-6m; middle) and Muc1 AT2−/− mice with 6 months CS exposure (CS-6m, right), respectively

Journal: Signal Transduction and Targeted Therapy

Article Title: MUC1 attenuates chronic obstructive pulmonary disease through integrated regulation of pulmonary epithelial cell senescence, transdifferentiation, and inflammatory cascades

doi: 10.1038/s41392-026-03056-x

Figure Lengend Snippet: MUC1 inhibits CS-induced pulmonary inflammatory responses by suppressing NF-κB-dependent signaling. a ELISA analysis of IL-6 and IL-8 levels in the culture supernatant of 16HBE cells treated with negative control siRNA (siNC) or MUC1 -targeting siRNA (si MUC1 ) for 48 h, followed by treatment with or without CSE for 24 h ( n = 6 per group). Cytokine concentrations were quantified in pg/mL and normalized to total protein content in each sample. b Western blot image and intensity analysis of NF-κB protein expression in the nuclear fraction of 16HBE cells treated with either negative control siRNA (siNC) or MUC1 -targeting siRNA (si MUC1 ) for 48 h, followed by treatment with or without CSE for 1 h ( n = 6 per group). Histone H3 was taken as the internal control. c Western blot image and intensity analysis of NF-κB protein expression in the nuclear fraction from lung tissues of Muc1 +/+ and Muc1 −/− mice exposed to air or CS ( n = 6 per group). Histone H3 was taken as the internal control. d Left: Cold competition assay was performed with nuclear extracts from Muc1 AT2−/− CS-6m mouse lungs. Middle and Right: EMSAs including negative control, cold competition, mutant cold probe competition, and super-shift assays were performed with nuclear extracts from lung tissues of Muc1 AT2+/+ mice with 6 months air exposure (Air-6m; middle) and Muc1 AT2−/− mice with 6 months CS exposure (CS-6m, right), respectively

Article Snippet: 2AT2 cell-specific Muc1 conditional knockout mice (Sftpc-CreERT2/ Muc1 flox/flox ) were purchased from Cyagen (Suzhou) Biotechnology Co. Ltd. (Suzhou, China).

Techniques: Enzyme-linked Immunosorbent Assay, Analysis, Negative Control, Western Blot, Expressing, Control, Competitive Binding Assay, Mutagenesis, Cell Culture

Schematic diagram of the study. In pulmonary epithelial cells under CS exposure, with the presence of MUC1: ① ATAD3A facilitates PINK1 translocation from the outer mitochondrial membrane (OMM) to the inner mitochondrial membrane (IMM) for PARL-mediated cleavage. MUC1-C interacts with ATAD3A and AMPK, thereby promoting PINK1 accumulation on the OMM, initiating mitophagy, and regulating metabolic reprogramming. ② MUC1-C interacts with β-catenin and translocates to the nucleus, where it regulates AT2-to-AT1 transdifferentiation and the expression of PINK1, HK2, and LDHA. ③ Loss of MUC1-C promotes NF-κB nuclear translocation, thereby upregulating IL-6/IL-8 transcription and inducing SASP secretion. ④ MUC1-C deficiency downregulates NDUFS4 in mitochondrial Complex I, leading to incomplete Complex I assembly. This reduces NADH enzymatic activity, causing NADH accumulation and O 2 •− leakage that elevates ROS, and causes cell senescence. This mechanistic schematic diagram was generated using BioRender ( https://biorender.com/ )

Journal: Signal Transduction and Targeted Therapy

Article Title: MUC1 attenuates chronic obstructive pulmonary disease through integrated regulation of pulmonary epithelial cell senescence, transdifferentiation, and inflammatory cascades

doi: 10.1038/s41392-026-03056-x

Figure Lengend Snippet: Schematic diagram of the study. In pulmonary epithelial cells under CS exposure, with the presence of MUC1: ① ATAD3A facilitates PINK1 translocation from the outer mitochondrial membrane (OMM) to the inner mitochondrial membrane (IMM) for PARL-mediated cleavage. MUC1-C interacts with ATAD3A and AMPK, thereby promoting PINK1 accumulation on the OMM, initiating mitophagy, and regulating metabolic reprogramming. ② MUC1-C interacts with β-catenin and translocates to the nucleus, where it regulates AT2-to-AT1 transdifferentiation and the expression of PINK1, HK2, and LDHA. ③ Loss of MUC1-C promotes NF-κB nuclear translocation, thereby upregulating IL-6/IL-8 transcription and inducing SASP secretion. ④ MUC1-C deficiency downregulates NDUFS4 in mitochondrial Complex I, leading to incomplete Complex I assembly. This reduces NADH enzymatic activity, causing NADH accumulation and O 2 •− leakage that elevates ROS, and causes cell senescence. This mechanistic schematic diagram was generated using BioRender ( https://biorender.com/ )

Article Snippet: 2AT2 cell-specific Muc1 conditional knockout mice (Sftpc-CreERT2/ Muc1 flox/flox ) were purchased from Cyagen (Suzhou) Biotechnology Co. Ltd. (Suzhou, China).

Techniques: Translocation Assay, Membrane, Expressing, Activity Assay, Generated

(A) Locations of the deleted fragment (1610 bp), amplicons, gRNAs, and primers matched to the Ttc22 gene. The conservation status of Ttc22 in placental mammals, including rats, rabbits, and humans, is displayed below. (B) Characterization of Ttc22 genotypes, as determined by PCR and sequencing. The wild-type Ttc22 fragment is too long (2438 bp) to be amplified via regular PCR via the OuterF and OuterR primer sets. (C) IGV view of Ttc22 transcripts in RNA samples from the colons of three male mice with different Ttc22 genotypes, namely, Ttc22 wild-type ( Ttc22 +/+ ), heterozygously deleted ( Ttc22 +/- ), and homozygously deleted ( Ttc22 -/- ) strains, as determined by RNA sequencing. The exon 2&3 region, which is shared by both Ttc22 variants 1 and 2 and is knocked out by CRISPR-Cas9, is highlighted by a red rectangle.

Journal: PLOS One

Article Title: No phenotypes in Ttc22 knockout mice

doi: 10.1371/journal.pone.0361340

Figure Lengend Snippet: (A) Locations of the deleted fragment (1610 bp), amplicons, gRNAs, and primers matched to the Ttc22 gene. The conservation status of Ttc22 in placental mammals, including rats, rabbits, and humans, is displayed below. (B) Characterization of Ttc22 genotypes, as determined by PCR and sequencing. The wild-type Ttc22 fragment is too long (2438 bp) to be amplified via regular PCR via the OuterF and OuterR primer sets. (C) IGV view of Ttc22 transcripts in RNA samples from the colons of three male mice with different Ttc22 genotypes, namely, Ttc22 wild-type ( Ttc22 +/+ ), heterozygously deleted ( Ttc22 +/- ), and homozygously deleted ( Ttc22 -/- ) strains, as determined by RNA sequencing. The exon 2&3 region, which is shared by both Ttc22 variants 1 and 2 and is knocked out by CRISPR-Cas9, is highlighted by a red rectangle.

Article Snippet: Genetically established Ttc22 knockout (Ttc22-KO) C57BL/6N mice (strain S-KO-06335) were purchased from Cyagen (Cyagen Bio.

Techniques: Sequencing, Amplification, RNA Sequencing, CRISPR

(A) Illustration of wild-type Ttc22 and its TPR1- or TPR4-deleted (ΔTPR1 or ΔTPR4) expression vectors. (B) Western blot images of the full-length (FL)/wild-type Ttc22 protein and its ΔTPR1 or ΔTPR4 variant overexpressed in HEK293T cells. (C) The abundance of the Ttc22 protein in mouse colon tissues from three groups of mice, as determined by Western blotting. (D) Characterization of Ttc22 genotypes in mouse colon tissues, as determined by PCR via a pooled primer set, including OuterF, InnerF, and OuterR.

Journal: PLOS One

Article Title: No phenotypes in Ttc22 knockout mice

doi: 10.1371/journal.pone.0361340

Figure Lengend Snippet: (A) Illustration of wild-type Ttc22 and its TPR1- or TPR4-deleted (ΔTPR1 or ΔTPR4) expression vectors. (B) Western blot images of the full-length (FL)/wild-type Ttc22 protein and its ΔTPR1 or ΔTPR4 variant overexpressed in HEK293T cells. (C) The abundance of the Ttc22 protein in mouse colon tissues from three groups of mice, as determined by Western blotting. (D) Characterization of Ttc22 genotypes in mouse colon tissues, as determined by PCR via a pooled primer set, including OuterF, InnerF, and OuterR.

Article Snippet: Genetically established Ttc22 knockout (Ttc22-KO) C57BL/6N mice (strain S-KO-06335) were purchased from Cyagen (Cyagen Bio.

Techniques: Expressing, Western Blot, Variant Assay

The appearance of C57BL/6N male and female C57BL/6N mice with different Ttc22 genotypes at approximately 66 and 77 weeks of age.

Journal: PLOS One

Article Title: No phenotypes in Ttc22 knockout mice

doi: 10.1371/journal.pone.0361340

Figure Lengend Snippet: The appearance of C57BL/6N male and female C57BL/6N mice with different Ttc22 genotypes at approximately 66 and 77 weeks of age.

Article Snippet: Genetically established Ttc22 knockout (Ttc22-KO) C57BL/6N mice (strain S-KO-06335) were purchased from Cyagen (Cyagen Bio.

Techniques:

Mating pairs were monitored for litter production during the first pregnancy. Three pairs of wild-type ( Ttc22 +/+ ) mice and six pairs of homozygous knockout ( Ttc22 −/− ) mice were established. Each symbol represents a pair. The data are presented as the mean ± SD.

Journal: PLOS One

Article Title: No phenotypes in Ttc22 knockout mice

doi: 10.1371/journal.pone.0361340

Figure Lengend Snippet: Mating pairs were monitored for litter production during the first pregnancy. Three pairs of wild-type ( Ttc22 +/+ ) mice and six pairs of homozygous knockout ( Ttc22 −/− ) mice were established. Each symbol represents a pair. The data are presented as the mean ± SD.

Article Snippet: Genetically established Ttc22 knockout (Ttc22-KO) C57BL/6N mice (strain S-KO-06335) were purchased from Cyagen (Cyagen Bio.

Techniques: Knock-Out

Incidence and latency period of spontaneous tumors* in C57BL/6N mice with different Ttc22 genotypes.

Journal: PLOS One

Article Title: No phenotypes in Ttc22 knockout mice

doi: 10.1371/journal.pone.0361340

Figure Lengend Snippet: Incidence and latency period of spontaneous tumors* in C57BL/6N mice with different Ttc22 genotypes.

Article Snippet: Genetically established Ttc22 knockout (Ttc22-KO) C57BL/6N mice (strain S-KO-06335) were purchased from Cyagen (Cyagen Bio.

Techniques:

Enrichment scores for genes upregulated and downregulated by homozygous Ttc22 knockout in the colon of 57-week-old male mice.

Journal: PLOS One

Article Title: No phenotypes in Ttc22 knockout mice

doi: 10.1371/journal.pone.0361340

Figure Lengend Snippet: Enrichment scores for genes upregulated and downregulated by homozygous Ttc22 knockout in the colon of 57-week-old male mice.

Article Snippet: Genetically established Ttc22 knockout (Ttc22-KO) C57BL/6N mice (strain S-KO-06335) were purchased from Cyagen (Cyagen Bio.

Techniques: Knock-Out

The ratio of total m6A to total adenosine in RNA (m6A/rA) in the colon tissues of mice with various Ttc22 genotypes, as determined by mass.

Journal: PLOS One

Article Title: No phenotypes in Ttc22 knockout mice

doi: 10.1371/journal.pone.0361340

Figure Lengend Snippet: The ratio of total m6A to total adenosine in RNA (m6A/rA) in the colon tissues of mice with various Ttc22 genotypes, as determined by mass.

Article Snippet: Genetically established Ttc22 knockout (Ttc22-KO) C57BL/6N mice (strain S-KO-06335) were purchased from Cyagen (Cyagen Bio.

Techniques: